查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085382

臨床試驗包裝市場：2026-2032年全球市場預測（依包裝類型、試驗階段、劑型、容器類型、材料及最終用戶分類）

Clinical Trial Packaging Market by Packaging Type, Trial Phase, Dosage Form, Container Type, Material, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，臨床試驗包裝市場將成長至 26.2 億美元，複合年成長率為 8.66%。

主要市場統計數據
基準年 2025 14.6億美元
預計年份：2026年 15.7億美元
預測年份 2032 26.2億美元
複合年成長率 (%) 8.66%

臨床試驗包裝是保障試驗完整性、病人安全、臨床實驗藥物可追溯性和合規性的關鍵控制點。隨著申辦方日益全球化，進行適應性強、分散化和以患者為中心的試驗，包裝必須能夠保護臨床實驗藥物、維持盲法、支持隨機分組、確保標籤符合監管要求，並能滿足日益複雜的低溫運輸和室溫控制要求。

全球持續的臨床研究活動、生技藥品製劑、疫苗、癌症治療以及細胞和基因療法的快速發展，以及良好生產規範 (GMP)、良好分銷規範 (GDP)、ICH 良好臨床規範 (GCP)、歐盟臨床試驗法規 536/2014 附件 13 和美國 FDA 監管下日益成長的期望，共同塑造了當前的形勢。能夠提供符合規範的試劑盒設計、序列化操作、溫度監控、檢驗的標籤管理以及數位化供應鏈可視性的包裝合作夥伴，最有利於減少偏差、防止臨床實驗藥物浪費並改善以患者為中心的臨床實驗執行。

臨床試驗包裝格局的變革性變化

臨床試驗包裝環境正從以人工、臨床實驗為中心的流程轉向以柔軟性、即時可見性、法規可追溯性和患者獲取為中心的整合供應模式。分散式臨床試驗、直接患者分發、對照藥物採購的複雜性以及頻繁的方案修訂，迫使包裝團隊設計出能夠實現小規模批量生產、更快重新貼標流程和多區域兼容性的試劑盒，同時還要遵守各國特定的標籤檢視法規。

人工智慧對臨床試驗包裝的累積影響

人工智慧 (AI) 正在透過改進需求預測、需求計劃、標籤管理、品質審核、庫存分配和運輸異常管理，變革臨床試驗包裝營運。 AI 模型可以分析受試者入組模式、臨床實驗運作時間、給藥方案、方案變更、溫度偏差歷史記錄和倉庫存量基準，從而減少缺貨和過剩生產，這些都是盲法、適應性試驗和多國試驗中長期存在的挑戰。

臨床試驗包裝市場的關鍵區域洞察

隨著中國、印度、日本、韓國和澳洲等國憑藉大規模的患者群、專業的醫院、數位化醫療的普及以及完善的監管流程吸引著許多複雜的臨床研究項目，亞太地區的重要性日益凸顯。該地區對包裝合作夥伴的需求也隨之成長，這些合作夥伴需要具備多語言標籤能力、進口授權專業知識、濕度控制、柔軟性的倉儲網路以及生技藥品、疫苗和先進療法所需的低溫運輸運輸能力。北美地區仍然是重要的樞紐，這得益於美國和加拿大龐大的臨床試驗規模、美國食品藥物管理局（FDA）和加拿大衛生署的嚴格監管、高度專業化的物流體系、分散式臨床試驗模式的高普及率以及成熟的溫控配送基礎設施。

關鍵小組對全球臨床試驗包裝的見解

隨著新加坡、馬來西亞、泰國、越南、印尼和菲律賓不斷加強醫療基礎設施、研究網路和監管體系的完善，東協市場對跨國臨床試驗的重要性日益凸顯。東協地區的臨床試驗包裝必須滿足不同的語言要求、進口程序、熱帶潮濕環境、溫度控制以及各國特定的倫理審查時間表。海灣合作理事會（GCC）正發展成為區域研發和專科醫療中心，其包裝需求與高標準的醫院網路、生物製藥物流、精準醫療計畫以及海灣國家間的監管協調密切相關。

主要國家的發展趨勢正在影響臨床試驗包裝的需求。

美國憑藉其大規模的贊助商基礎、先進的臨床研究網路、受FDA監管的臨床試驗活動、專業的藥房能力以及分散式和專業化治療試驗的快速發展，推動了對臨床試驗包裝的需求。加拿大則擁有強大的學術研究基礎、加拿大衛生署的監管、雙語標籤檢視的需求以及可靠的低溫運輸基礎設施。墨西哥和巴西是拉丁美洲的關鍵市場，為患者招募提供了機會，大規模針對特定適應症的初治患者群體，以及不斷成長的臨床實驗中心網路。然而，這也要求在海關規劃、與當地監管機構的協調、進口文件以及穩健的臨床實驗中心間配送模式之間取得平衡。

為臨床試驗包裝負責人提供的實用建議。

產業領導者應將臨床試驗包裝視為方案設計早期階段的關鍵要素，而非下游生產環節。包裝、臨床營運、法規事務、品質保證、採購和物流團隊需要在試驗啟動前通力合作，共同製定試劑盒設計、隨機化策略、各國特定標籤檢視、補給觸發機制、溫度控制、對照品採購、退貨流程、處置流程以及方案變更的緊急時應對計畫。

臨床試驗中包裝分析的調查方法

本執行摘要基於對已核實的行業和監管資料的系統性審查，包括美國FDA、歐洲藥品管理局（EMA）、ICH良好臨床實踐（GCP）指南、歐盟臨床試驗法規536/2014附件13、GMP和GDP原則、各國衛生監管機構的要求以及公認的臨床試驗註冊趨勢。該檢驗評估了臨床實驗藥物、生物製藥、疫苗、低溫運輸療法、分散式研究模式、對照研究以及跨國附加檔環境的包裝資訊來源。

結論：臨床試驗包裝是策略性成長的驅動力

臨床試驗包裝如今在試驗的穩健性、合規性、臨床實驗藥物的完整性和患者可及性方面發揮核心作用。在全球規範日益嚴格的背景下，生物製藥、分散式營運、低溫運輸配送和監管力度不斷加大，柔軟性、經過驗證、數位化連接且能適應當地情況的包裝策略至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 臨床試驗包裝市場：依包裝類型分類

  • 阻隔袋
  • 吹塑密封袋
  • 墨水匣
  • 預填充注射器
  • 管瓶
    • 玻璃管瓶
    • 塑膠管瓶

第8章 臨床試驗包裝市場：依臨床試驗階段分類

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第9章：臨床試驗包裝市場：依劑型分類

  • 液體
    • 水溶液
    • 油性溶液
  • 冷凍乾燥製劑
  • 粉末製劑

第10章 臨床試驗包裝市場：依容器類型分類

  • 安瓿
  • 包包
    • 軟性袋
    • 硬質袋
  • 墨水匣
  • 注射器
    • 手動注射器
    • 預填充式注射器
  • 管瓶

第11章 臨床試驗包裝市場：依材料分類

  • 玻璃
  • 塑膠
    • 環烯烴共聚物
    • 環烯烴聚合物

第12章 臨床試驗包裝市場：依最終使用者分類

  • 製藥和生物技術公司
  • 臨床試驗包裝供應商
  • 受託研究機構
  • 醫院和臨床試驗點
  • 學術研究機構

第13章 臨床試驗包裝市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 臨床試驗包裝市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 臨床試驗包裝市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • ACG Capsules Private Limited
  • Almac Group Limited
  • Amcor Plc
  • Berry Global Inc.
  • Bilcare Limited
  • Catalent Pharma Solutions, Inc.
  • CCL Industries Inc.
  • EPL Limited
  • Fisher Clinical Services
  • Gaplast GmbH
  • Gerresheimer AG
  • Lonza Group
  • Marken Ltd.
  • Mondi PLC
  • PCI Services
  • Sealed Air Corporation
  • Sharp Packaging Services, Inc.
  • Stora Enso Oyj
  • Thermo Fisher Scientific Inc.
  • Tjoapack Group Holding BV
  • UDG Healthcare plc
  • URSATEC GmbH
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • WL Gore & Associates Inc.
  • Westrock Company
  • Wuxi AppTec
  • Xerimis Inc.
Product Code: MRR-4311CE1A33A7

The Clinical Trial Packaging Market is projected to grow by USD 2.62 billion at a CAGR of 8.66% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.46 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 2.62 billion
CAGR (%) 8.66%

Clinical trial packaging has become a strategic control point for trial integrity, patient safety, investigational product accountability, and regulatory readiness. As sponsors run more global, adaptive, decentralized, and patient-centric studies, packaging must protect investigational medicinal products, preserve blinding, support randomization, enable compliant labeling, and withstand increasingly complex cold chain and controlled room temperature requirements.

The landscape is shaped by sustained global clinical research activity, the expansion of biologics, vaccines, oncology therapies, and cell and gene therapies, and heightened expectations under Good Manufacturing Practice, Good Distribution Practice, ICH Good Clinical Practice, EU Clinical Trials Regulation No. 536/2014, Annex 13, and U.S. FDA oversight. Packaging partners that combine compliant kit design, serialization-ready operations, temperature monitoring, validated labeling controls, and digital supply chain visibility are best positioned to reduce deviations, prevent investigational drug waste, and improve patient-centric trial execution.

Transformative Shifts in the Clinical Trial Packaging Landscape

The clinical trial packaging landscape is moving from manual, site-centered workflows toward integrated supply models built around flexibility, real-time visibility, regulatory traceability, and patient access. Decentralized clinical trials, direct-to-patient distribution, comparator sourcing complexity, and frequent protocol amendments are pushing packaging teams to design smaller batch runs, faster relabeling processes, and kits that can serve multiple geographies without compromising country-specific labeling rules.

Transformative shifts are also being driven by biologics, oncology pipelines, orphan drug development, vaccine trials, and temperature-sensitive therapies. Sponsors increasingly require packaging configurations that support cold chain validation, tamper evidence, child resistance where applicable, low-waste overage strategies, medication adherence support, and rapid response to enrollment variability. These changes elevate clinical trial packaging from an operational function to a risk management capability that influences trial timelines, cost control, data reliability, and regulatory inspection readiness.

Cumulative Impact of Artificial Intelligence on Clinical Trial Packaging

Artificial intelligence is reshaping clinical trial packaging by improving forecasting, demand planning, label control, quality review, inventory allocation, and shipment exception management. AI-enabled models can analyze enrollment patterns, site activation timing, dosing schedules, protocol changes, temperature excursion histories, and depot inventory levels to reduce stockouts and overproduction, two persistent challenges in blinded, adaptive, and multi-country studies.

The cumulative impact is most visible when AI is combined with interactive response technology, electronic batch records, warehouse management systems, validated label management, and temperature monitoring platforms. While AI does not replace GMP accountability, qualified person release responsibilities, or human quality oversight, it strengthens decision support by identifying anomalies, prioritizing quality risks, improving packaging run planning, and accelerating corrective action. Industry leaders must pair AI adoption with validated systems, audit trails, data governance, cybersecurity controls, explainability, and documented human review to meet regulatory expectations.

Key Regional Insights Across Clinical Trial Packaging Markets

Asia-Pacific is gaining importance as China, India, Japan, South Korea, and Australia attract complex clinical research through large patient pools, specialist hospitals, digital health adoption, and improving regulatory pathways. The region requires packaging partners with multilingual labeling, import permit expertise, humidity control, depot network flexibility, and cold chain capabilities for biologics, vaccines, and advanced therapies. North America remains a leading hub due to the scale of U.S. and Canadian trial activity, strong FDA and Health Canada oversight, advanced specialty logistics, high adoption of decentralized clinical trial models, and mature temperature-controlled distribution infrastructure.

Europe continues to be shaped by EU Clinical Trials Regulation No. 536/2014, Annex 13 expectations for investigational medicinal products, qualified person release, and country-level language requirements that influence label design, booklet labels, and release planning. Latin America, led by Brazil and Mexico, is attractive for patient recruitment and therapeutic diversity but requires careful navigation of customs, ethics approvals, import licensing, and in-country distribution. The Middle East is expanding through GCC health infrastructure investment, specialty care development, and growing clinical research policy support, while Africa offers long-term opportunity in vaccine, infectious disease, maternal health, and public health studies where reliable temperature control, site readiness, and last-mile logistics are decisive.

Key Group Insights for Global Clinical Trial Packaging

ASEAN markets are becoming more relevant for multinational clinical trials as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines strengthen healthcare infrastructure, research networks, and regulatory maturity. Clinical trial packaging in ASEAN must address varied language requirements, import procedures, tropical humidity exposure, temperature control, and country-specific ethics timelines. The GCC is developing as a regional research and specialty care hub, with packaging demand linked to high-standard hospital networks, biologics logistics, precision medicine initiatives, and harmonization efforts across Gulf states.

The European Union sets a high benchmark for compliant investigational medicinal product packaging through centralized clinical trial rules, strict labeling controls, multilingual documentation, and qualified person release processes. BRICS economies bring scale, patient access, and manufacturing depth, but they also require localized regulatory intelligence across China, India, Brazil, Russia, and South Africa. G7 countries anchor premium clinical research demand through mature regulatory systems, advanced cold chain networks, and high participation in innovative therapy development, while NATO-aligned markets benefit from established quality systems, secure logistics, and resilient cross-border supply capabilities that support continuity planning for clinical trial packaging and distribution.

Key Country Insights Shaping Clinical Trial Packaging Demand

The United States leads demand for clinical trial packaging through a large sponsor base, advanced clinical research networks, FDA-regulated trial activity, specialty pharmacy capabilities, and rapid adoption of decentralized and specialty therapy trials. Canada adds strong academic research, Health Canada oversight, bilingual labeling needs, and reliable cold chain infrastructure. Mexico and Brazil are key Latin American markets where patient recruitment opportunities, large treatment-naive populations in selected indications, and expanding site networks must be balanced with customs planning, local regulatory coordination, import documentation, and robust site distribution models.

In Europe, the United Kingdom remains influential through MHRA oversight, strong early-phase research, and advanced life sciences infrastructure, while Germany, France, Italy, and Spain support broad trial activity across oncology, immunology, rare disease, and chronic disease. Russia requires careful regulatory, logistics, sanctions, and geopolitical risk evaluation before trial supply planning. In Asia-Pacific, China and India provide scale, expanding innovation pipelines, and growing domestic biopharma activity; Japan demands high quality, precise documentation, and strict process control; Australia is valued for early-phase studies and regulatory efficiency; and South Korea combines advanced hospitals, digital health capability, and strong biopharma investment to support sophisticated clinical trial packaging requirements.

Actionable Recommendations for Clinical Trial Packaging Leaders

Industry leaders should treat clinical trial packaging as an early-stage protocol design input rather than a downstream production task. Packaging, clinical operations, regulatory affairs, quality assurance, procurement, and logistics teams should align before study startup on kit design, randomization strategy, country labeling, resupply triggers, temperature controls, comparator sourcing, return procedures, destruction pathways, and contingency plans for protocol amendments.

Sponsors and packaging providers should invest in validated digital platforms, AI-assisted forecasting, serialization-ready processes, sustainable material selection, validated label management, and qualified cold chain lanes. The strongest operators will maintain redundant packaging capacity, supplier risk monitoring, comparator sourcing governance, temperature excursion playbooks, audit-ready documentation, and documented deviation response procedures that protect patient safety while reducing trial delays and investigational product waste.

Research Methodology for Clinical Trial Packaging Analysis

This executive summary is built on a structured review of verified industry and regulatory sources, including publicly available guidance from the U.S. FDA, European Medicines Agency, ICH Good Clinical Practice, EU Clinical Trials Regulation No. 536/2014, Annex 13, GMP and GDP principles, national health authority requirements, and recognized clinical trial registry trends. The analysis evaluates packaging requirements across investigational medicinal products, biologics, vaccines, cold chain therapies, decentralized trial models, comparator studies, and multinational labeling environments.

The methodology combines secondary research, regulatory benchmarking, market signal analysis, and assessment of clinical trial supply chain practices. Insights are organized by region, economic group, and priority country to support SEO relevance and executive decision-making. The findings emphasize evidence-based drivers, operational risks, compliance considerations, and practical actions rather than speculative market sizing, market share, or forecasting.

Conclusion: Clinical Trial Packaging as a Strategic Growth Enabler

Clinical trial packaging is now central to trial resilience, compliance, investigational product integrity, and patient access. The increasing complexity of global protocols, biologic therapies, decentralized operations, cold chain distribution, and regulatory scrutiny requires packaging strategies that are flexible, validated, digitally connected, and regionally informed.

Organizations that integrate AI-enabled planning, compliant labeling, cold chain assurance, validated quality systems, and patient-centric kit design will be better equipped to reduce waste, support enrollment continuity, improve supply reliability, and safeguard investigational product integrity. As clinical research expands across established and emerging markets, packaging excellence will remain a competitive differentiator for sponsors, contract research organizations, development and manufacturing partners, and specialty logistics providers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Clinical Trial Packaging Market, by Packaging Type

  • 7.1. Barrier Bag
  • 7.2. Blow Fill Seal Pouch
  • 7.3. Cartridge
  • 7.4. Prefillable Syringe
  • 7.5. Vial
    • 7.5.1. Glass Vial
    • 7.5.2. Plastic Vial

8. Clinical Trial Packaging Market, by Trial Phase

  • 8.1. Phase I
  • 8.2. Phase II
  • 8.3. Phase III
  • 8.4. Phase IV

9. Clinical Trial Packaging Market, by Dosage Form

  • 9.1. Liquid Formulations
    • 9.1.1. Aqueous Solutions
    • 9.1.2. Oily Solutions
  • 9.2. Lyophilized Formulations
  • 9.3. Powdered Formulations

10. Clinical Trial Packaging Market, by Container Type

  • 10.1. Ampoule
  • 10.2. Bag
    • 10.2.1. Flexible Bag
    • 10.2.2. Rigid Bag
  • 10.3. Cartridge
  • 10.4. Syringe
    • 10.4.1. Manual Syringe
    • 10.4.2. Prefilled Syringe
  • 10.5. Vial

11. Clinical Trial Packaging Market, by Material

  • 11.1. Glass
  • 11.2. Plastic
    • 11.2.1. Cyclo Olefin Copolymer
    • 11.2.2. Cyclo Olefin Polymer

12. Clinical Trial Packaging Market, by End User

  • 12.1. Pharmaceutical & Biotech Companies
  • 12.2. Clinical Trial Packaging Providers
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinical Sites
  • 12.5. Academic Research Institutions

13. Clinical Trial Packaging Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Clinical Trial Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Clinical Trial Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. ACG Capsules Private Limited
  • 17.2. Almac Group Limited
  • 17.3. Amcor Plc
  • 17.4. Berry Global Inc.
  • 17.5. Bilcare Limited
  • 17.6. Catalent Pharma Solutions, Inc.
  • 17.7. CCL Industries Inc.
  • 17.8. EPL Limited
  • 17.9. Fisher Clinical Services
  • 17.10. Gaplast GmbH
  • 17.11. Gerresheimer AG
  • 17.12. Lonza Group
  • 17.13. Marken Ltd.
  • 17.14. Mondi PLC
  • 17.15. PCI Services
  • 17.16. Sealed Air Corporation
  • 17.17. Sharp Packaging Services, Inc.
  • 17.18. Stora Enso Oyj
  • 17.19. Thermo Fisher Scientific Inc.
  • 17.20. Tjoapack Group Holding B.V.
  • 17.21. UDG Healthcare plc
  • 17.22. URSATEC GmbH
  • 17.23. Vetter Pharma-Fertigung GmbH & Co. KG
  • 17.24. W. L. Gore & Associates Inc.
  • 17.25. Westrock Company
  • 17.26. Wuxi AppTec
  • 17.27. Xerimis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL PACKAGING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CLINICAL TRIAL PACKAGING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BARRIER BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BARRIER BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BARRIER BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOW FILL SEAL POUCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOW FILL SEAL POUCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOW FILL SEAL POUCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARTRIDGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARTRIDGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARTRIDGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PREFILLABLE SYRINGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PREFILLABLE SYRINGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PREFILLABLE SYRINGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLASS VIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLASS VIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GLASS VIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLASTIC VIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLASTIC VIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLASTIC VIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHASE I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHASE II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHASE III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHASE IV MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHASE IV MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHASE IV MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AQUEOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OILY SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OILY SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OILY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LYOPHILIZED FORMULATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LYOPHILIZED FORMULATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LYOPHILIZED FORMULATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POWDERED FORMULATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POWDERED FORMULATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POWDERED FORMULATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMPOULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMPOULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AMPOULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FLEXIBLE BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLEXIBLE BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLEXIBLE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RIGID BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RIGID BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RIGID BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARTRIDGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARTRIDGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARTRIDGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SYRINGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SYRINGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SYRINGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MANUAL SYRINGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MANUAL SYRINGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MANUAL SYRINGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLASTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLASTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLASTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CYCLO OLEFIN COPOLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CYCLO OLEFIN COPOLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CYCLO OLEFIN COPOLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CYCLO OLEFIN POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CYCLO OLEFIN POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CYCLO OLEFIN POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICAL TRIAL PACKAGING PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CLINICAL TRIAL PACKAGING PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CLINICAL TRIAL PACKAGING PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOSPITALS & CLINICAL SITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOSPITALS & CLINICAL SITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOSPITALS & CLINICAL SITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACADEMIC RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ACADEMIC RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACADEMIC RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 199. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 201. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 204. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 206. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 235. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 237. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 240. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 242. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 243. G7 CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 247. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 249. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 252. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 255. NATO CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 347. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2032 (USD MILLION)
  • TABLE 349. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIAL, 2018-2032 (USD MILLION)
  • TABLE 356. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY TRIAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 357. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 358. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 359. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 360. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAG, 2018-2